Azeria Therapeutics Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Liquidation
- Investors
-
1
Azeria Therapeutics General Information
Description
Developer of small-molecule pipeline devices designed to aid in the treatment of breast and prostate cancer. The company's devices develop treatments for hormone-resistant breast cancer patients where there are significant areas of unmet clinical need to selectively inhibit pioneer factors, enabling healthcare organizations and medical professionals to treat multiple cancer types.
Contact Information
Website
www.azeriatherapeutics.comCorporate Office
- CRUK Cambridge Institute
- Robinson Way
- Cambridge CB2 0RE
- England, United Kingdom
Corporate Office
- CRUK Cambridge Institute
- Robinson Way
- Cambridge CB2 0RE
- England, United Kingdom
Azeria Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Bankruptcy: Liquidation | 08-Dec-2020 | Completed | Bankruptcy: Liquidation | |||
| 3. Early Stage VC (Series B) | 21-Nov-2019 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 04-Sep-2018 | $5.14M | $5.14M | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2017 | Completed | Generating Revenue |
Azeria Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Azeria Therapeutics Comparisons
Industry
Financing
Details
Azeria Therapeutics Competitors (16)
One of Azeria Therapeutics’s 16 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Volastra | Venture Capital-Backed | New York, NY | ||||
| Ona Therapeutics | Venture Capital-Backed | Barcelona, Spain | ||||
| Gesynta Pharma | Venture Capital-Backed | Stockholm, Sweden | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain |
Azeria Therapeutics Patents
Azeria Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201916968-D0 | Means and method for treating cancer | Inactive | 21-Nov-2019 | ||
| GB-201909228-D0 | Screen for inhibitors | Inactive | 27-Jun-2019 | ||
| WO-2020260899-A1 | Screen for inhibitors | Inactive | 27-Jun-2019 | ||
| GB-201905318-D0 | Inhibitor compounds | Inactive | 15-Apr-2019 | ||
| GB-201905328-D0 | Inhibitor compounds | Inactive | 15-Apr-2019 |
Azeria Therapeutics Signals
Azeria Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| University of Cambridge | University |
Azeria Therapeutics FAQs
-
When was Azeria Therapeutics founded?
Azeria Therapeutics was founded in 2017.
-
Where is Azeria Therapeutics headquartered?
Azeria Therapeutics is headquartered in Cambridge, United Kingdom.
-
What is the size of Azeria Therapeutics?
Azeria Therapeutics has 11 total employees.
-
What industry is Azeria Therapeutics in?
Azeria Therapeutics’s primary industry is Other Healthcare Technology Systems.
-
Is Azeria Therapeutics a private or public company?
Azeria Therapeutics is a Private company.
-
What is Azeria Therapeutics’s current revenue?
The current revenue for Azeria Therapeutics is .
-
How much funding has Azeria Therapeutics raised over time?
Azeria Therapeutics has raised $46.4M.
-
Who are Azeria Therapeutics’s investors?
University of Cambridge has invested in Azeria Therapeutics.
-
Who are Azeria Therapeutics’s competitors?
Genentech, Volastra, Ona Therapeutics, Gesynta Pharma, and Ability Pharma are some of the 16 competitors of Azeria Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process